LAUSR

Abstract Hypoplastic left heart syndrome is associated with a substantial interstage mortality between the Stage I neonatal Norwood operation and the Stage II bidirectional cavopulmonary anastomosis. One of the many endeavors to reduce interstage mortality has been the development of interstage home monitoring programs. We review the efficacy of interstage monitoring programs in general and in particularly at our center and conclude that interstage monitoring does make a difference. All programs, however, are not the same. Further research is needed to ascertain which facets of interstage monitoring truly impact outcomes and restructure monitoring programs as such.